Prosecution Insights
Prosecution Insights
Technology area: Biotechnology & Pharmaceuticals
2 pending office actions • 2 art units • 2 examiners • 0 of 2 (0%) have an AI response strategy ready • 2 patents granted in the last 365 days
Accencio LLC currently manages a patent portfolio within the Biotechnology & Pharmaceuticals technology area. The prosecution pipeline contains 3 pending office actions, which are distributed across 3 distinct examiners. The fact that the number of actions matches the number of examiners suggests a broad spread of intellectual property oversight. The portfolio also reaches across 3 distinct art units, showing that the company's legal strategy involves multiple specialized divisions within the patent office.
LAUREN QUINLAN WELLS is the busiest examiner associated with the portfolio, currently handling 1 pending office action. Since the total count of pending office actions is 3, this busiest examiner manages a portion of the active cases while other examiners handle the remainder. Practitioners should note that the 3 distinct art units involved may apply different examination standards or timelines to the pending applications. The presence of 3 distinct examiners across 3 distinct art units indicates that the prosecution experience is not centralized under a specific administrative group.
Based on the USPTO statutory response window for each pending office action. 2 of the docket's apps have a known mailing date; the rest are excluded from the tile counts.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §101 + other | 1 (50%) |
| Multi-statute (no §101) | 1 (50%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| WELLS, LAUREN QUINLAN | 1 | 48.4% | +60.3% |
| KALLAL, ROBERT JAMES | 1 | 60.0% | +32.4% |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17571840 | SYSTEM AND METHOD FOR EVALUATING BIOLOGICAL DATA USING AND APPLYING A VIRTUAL LANDSCAPE | KALLAL, ROBERT JAMES | 60d overdue |
| 18044964 | METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION | WELLS, LAUREN QUINLAN | 4d overdue |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 17571840 | SYSTEM AND METHOD FOR EVALUATING BIOLOGICAL DATA USING AND APPLYING A VIRTUAL LANDSCAPE | KALLAL, ROBERT JAMES | 60d overdue |
| 18044964 | METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION | WELLS, LAUREN QUINLAN | 4d overdue |
| Art Unit | Apps |
|---|---|
| 1622 | 1 |
| 1685 | 1 |
| App # | Title | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|
| 18044964 | METHODS OF TREATING SYMPTOMS OF CORONAVIRUS INFECTION | WELLS, LAUREN QUINLAN | 1622 | §102§103§112 | Final Rejection | 4d overdue | Pending | Mar 10, 2023 |
| 17571840 | SYSTEM AND METHOD FOR EVALUATING BIOLOGICAL DATA USING AND APPLYING A VIRTUAL LANDSCAPE | KALLAL, ROBERT JAMES | 1685 | §101§103 | Final Rejection | 60d overdue | Pending | Jan 10, 2022 |
IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial